揭示肌缩性侧面硬化症的复杂性:来自蛋白质组学,代谢组学和微生物组学的见解
Simone Scarcella1, Lorenzo Brambilla2, Lorenzo Quetti2
1Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Università degli Studi di Milano, 20122 Milan, Italy.
Brain communications
|March 31, 2025
概括
包括蛋白质组学,代谢组学和微生物组学在内的多种组学方法对于理解肌缩性侧面硬化症 (ALS) 病变发生至关重要. 整合这些omics数据有助于识别生物标志物和开发针对ALS的向疗法.
科学领域:
- 神经退行性疾病 神经退行性疾病
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种渐进的运动神经元疾病,没有特定的疾病修饰治疗.
- 了解ALS病理机制是开发有效疗法的关键.
- 多组学技术为解剖复杂的疾病过程提供了强大的工具.
研究的目的:
- 审查有关蛋白质组学,代谢组学,脂质组学和微生物组学在ALS中的作用的文献.
- 突出多组学数据集成对了解ALS病原学的重要性.
- 为了确定ALS诊断,预后和治疗反应的潜在生物标志物.
主要方法:
- 综合文献综述,重点关注ALS中的蛋白质组学,代谢组学,脂质组学和微生物组学研究.
- 对这些奥米克方法的分析阐明了ALS中的分子机制和代谢变化.
- 整合多组数据以了解疾病进展和因素之间的相互作用.
主要成果:
- 蛋白质组学揭示了错误折叠/聚合蛋白在ALS病变发生过程中的作用.
- 代谢和脂质学研究确定了ALS中复杂的代谢变化.
- 微生物组学数据提供了关于ALS中微生物动态和代谢失调之间的相互作用的见解.
结论:
- 多组学方法对于揭开ALS病理机制和确定治疗点至关重要.
- 蛋白质组学,代谢组学,脂质组学和微生物组学数据的整合提高了对ALS的理解.
- 这种综合方法可以加速开发针对ALS的特定和有效治疗方法.
更多相关视频
09:52A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
Published on: January 10, 2025
456
07:28JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
Published on: October 19, 2021
3.1K
相关概念视频
01:33Proteomics
7.1K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.1K
03:03Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K